Peter Brown

Stock price provided by Lang & Schwarz

Showing transactions by Peter Brown in Vertex Pharmaceuticals Incorporated.

Quarter	Type	Shares before	Shares after	Change	Price range
2025-Q1	Sell	1.4M	1.2M	-226K	€387.10–€472.90
2024-Q4	Sell	1.6M	1.4M	-234K	€381.70–€487.20
2024-Q3	Buy	1.6M	1.6M	+65K	€412.65–€468.00
2024-Q2	Sell	1.6M	1.6M	-14K	€368.15–€452.65
2024-Q1	Sell	1.6M	1.6M	-11K	€374.80–€408.50
2023-Q4	Sell	1.7M	1.6M	-72K	€315.15–€376.05
2023-Q3	Buy	1.3M	1.7M	+392K	€308.40–€334.90
2023-Q2	Sell	1.4M	1.3M	-126K	€285.90–€323.40
2023-Q1	Sell	2.2M	1.4M	-849K	€264.60–€295.70
2022-Q4	Buy	2.1M	2.2M	+108K	€268.50–€318.70
2022-Q3	Buy	1.8M	2.1M	+378K	€267.60–€300.00
2022-Q2	Buy	1.7M	1.8M	+54K	€222.58–€277.98
2022-Q1	Buy	1.6M	1.7M	+81K	€194.10–€232.40
2021-Q4	Sell	1.9M	1.6M	-265K	€153.50–€197.24
2021-Q3	Sell	2.3M	1.9M	-386K	€156.24–€172.30
2021-Q2	Sell	2.4M	2.3M	-123K	€156.04–€185.48
2021-Q1	Sell	3.6M	2.4M	-1.2M	€172.34–€199.04
2020-Q4	Sell	5.2M	3.6M	-1.6M	€174.16–€236.45
2020-Q3	Sell	5.8M	5.2M	-574K	€215.80–€267.20
2020-Q2	Sell	6.9M	5.8M	-1.1M	€205.55–€268.45
2020-Q1	Sell	7.1M	6.9M	-217K	€181.00–€229.20
2019-Q4	Buy	5.8M	7.1M	+1.3M	€152.54–€202.00
2019-Q3	Buy	5.6M	5.8M	+243K	€148.90–€168.12
2019-Q2	Buy	5.1M	5.6M	+477K	€146.02–€169.04
2019-Q1	Buy	4.3M	5.1M	+744K	€143.34–€171.20
2018-Q4	Buy	4.1M	4.3M	+245K	€137.99–€166.77
2018-Q3	Buy	2.9M	4.1M	+1.2M	€143.10–€166.35
2018-Q1	Buy	2.8M	2.9M	+3K	€120.57–€143.96
2017-Q4	Buy	1.4M	2.8M	+1.5M	€116.36–€132.19
2017-Q3	Buy	22K	1.4M	+1.3M	€111.42–€141.99
2017-Q2	Sell	40K	22K	-18K	€101.20–€121.85
2017-Q1	Sell	61K	40K	-20K	€70.06–€101.70
2016-Q2	Sell	113K	61K	-52K
2016-Q1	Buy	61K	113K	+51K
2015-Q4	Sell	159K	61K	-98K
2015-Q1	Sell	312K	159K	-153K
2014-Q1	Buy	139K	312K	+173K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors